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pCoronary atherosclerosis is a highly prevalent and
progressive disorder that is characterized by a long
latent phase before the onset of clinical symptoms.
Fatty streaks are commonly found in the vascular
walls of children and progress with high frequency
to significant fibrous plaques by early adulthood
(1,2). Some of these evolve to become susceptible to
hemorrhage, rupture, and thrombosis, with resul-
tant acute coronary events. Because these events
frequently occur without premonitory symptoms,
the need to initiate management and prevention of
coronary artery disease (CAD) well before the
See page 923
development of clinically manifest heart disease is
now well accepted. Recent panels recommend the
use of coronary artery calcium (CAC) scanning or
carotid ultrasound for screening those asymptom-
atic individuals with an intermediate Framingham
Risk Score (FRS) (3), but these recommendations
are largely based on the study of populations older
than 50 years of age. There is currently no consen-
sus regarding whether and how to screen for CAD
in early middle age.
This issue is addressed in an important new study
by Okwuosa et al. (4) in this issue of iJACC. In their
investigation, they assessed the prevalence and dis-
tribution of CAC according to FRS levels among
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GE Healthcare and Siemens.3- to 45-year-old individuals in the CARDIA
Coronary Artery Risk Development in Young
dults) study. As part of their analysis, they as-
essed a new metric proposed by Rembold (5):
ssessment of screening benefit according to the
umber needed to screen (NNS). In the present
tudy, the NNS is based on the number of individ-
als needed to screen to detect CAC abnormality,
ith separate NNS values determined for detecting
AC scores0 and100. In their cohort of 2,831
ndividuals, the prevalence of a CAC score 0 was
.9% and a CAC score 100 was 1.8%. Their
rincipal conclusion is that application of CAC
canning in only 33- to 45-year-old individuals with
FRS 10% can be beneficial because in this
ubgroup CAC scores 100 occur with high fre-
uency (17.2%), resulting in a low NNS (6). We
xamine these findings from 4 perspectives: the
ptimal goal of testing, the utility of NNS, the use
f the FRS, and the overall relevance of screening
or CAC in young adults.
he Goal of Testing Young Middle-Age Adults
he assessment of a test’s effectiveness is critically
ependent on the predominant goal of testing. A
ey question in analyzing the findings of the
ARDIA study is whether the optimal goal should
e the detection of the 2% with a CAC score of
100 or the detection of the 10% with a CAC
core0. We suggest that the better goal should be
he detection of any CAC, based on 3 observations.
irst, the presence of any CAC provides definitive
vidence of atherosclerosis and can thus be viewed
s sufficient evidence to manage CAD risk factors
ggressively. Second, because CAC is not common-
lace among adults who are 33 to 45 years old, the
etection of any CAC abnormality in such adults
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932already identifies those at relatively high long-term
risk of cardiac events. For instance, even when one
just considers individuals at the upper limit of their
cohort’s age range, men at 45 years, those with
CAC scores of only 5 to 10 are already within the
80th to 85th percentiles and women are within the
95th percentile for CAC abnormality. The absolute
CAC score is a better predictor of clinical outcomes
than percentile score, but subjects with such high
CAC percentile scores are nevertheless at decidedly
high risk of the development of subsequent clinical
events (6). Third, the importance of even mild
CAC abnormalities was underscored by 2 recent
large studies that found that CAC scores of only 1
to 10 increased subsequent clinical event rates by 2-
to 3-fold compared with CAC scores of 0 (7,8).
Combined, these observations provide a strong
rationale for developing a screening strategy based
on detecting CAC scores 0 rather than 100.
Number Needed to Screen
What might constitute an optimal NNS may be
influenced by a complexity of factors, including the
nature of the study population and the conse-
quences of testing. Thus, this metric deserves fur-
ther study to assess its practical clinical utility.
Although Okwuosa et al. (4) derived that the NNS
to detect a CAC score of 100 is 6 for a FRS
10, reassessment of their data reveal that the NNS
or the alternative goal of detecting a CAC score 0
ould be only 3.6 based on an FRS threshold of5%
Table 1). Of note, screening subjects with an FRS
5% instead of10% would only increase the total
ercentage of subjects screened from 2% to 6% in
he CARDIA study. The rationale for using an
RS 5% as a triage point for young adults is
upported by the findings of the Prospective Army
oronary Calcium Project, which followed a
creened adult population with a mean age of 42 for
.6 years after CAC scanning (9). During follow-
p,1% of subjects with an FRS5% experienced
cardiac event compared with 28.6% of the subjects
ith an FRS 5%.
Table 1. Number Needed to Screen to Detect CAC Abnormality
FRS Threshold, %
No. of Subjects
Above Threshold
% of Tota
Subjects
10 58 2.0
5 173 6.1
2.5 460 16.2
Adapted from the data of Okwuosa et al. (4).
CAC  coronary artery calcium; FRS  Framingham Risk Score; NNS  number neUse of the FRS as the Triage Criterion
for CAC Screening in Younger Adults
The FRS considers age, sex, serum cholesterol,
blood pressure, diabetes, and smoking status. How-
ever, the FRS does not consider other important
parameters of risk that can shape long-term out-
comes among younger adults, including obesity, the
presence of a family history of premature heart
disease, physical inactivity and/or poor fitness, and
the chronicity of risk factors. Notably, in this
regard, because of the very high weighting given to
age in the formulation of the FRS, many younger
subjects with important CAD risk factors have only
modest increases in FRS. This potential limitation
of the FRS also extends to women older than 45
years of age. For instance, in the population-based
MESA (Multi-Ethnic Study of Atherosclerosis),
90% of women older than 45 years of age were
classified as low risk by FRS (10% in 10 years).
Thirty-two percent of these women had a CAC
score 0, and their hazard ratio for cardiac events
was 6.5 compared with those with a CAC score of
0 (10). Given these limitations, we suggest that
the use of the FRS is not an optimal means of
triaging younger adults for screening tests. In-
deed, previous work from the CARDIA study
established that increased body mass index, a
family history of premature CAD, and the chro-
nicity of CAD risk factors are all predictors of
CAC abnormality in individuals between the ages
of 33 and 45 years (11–13). Thus, a triaging
algorithm that includes all CAD risk factors
might be preferable to use instead of the FRS in
young adults. Future algorithm should further
distinguish the practical minimal age range for
applying CAC scanning in women versus men.
Clinical Relevance
Not only is cardiac risk assessment challenging
among younger adults but so too is subsequent risk
management. Individuals between the ages of 33
and 45 years are predominantly asymptomatic and
re >0)
No. With CAC
Score >0
Prevalence of CAC
Score >0, % NNS
26 44.8 2.2
48 27.7 3.6
106 23.0 4.3(Sco
leded to screen.
m
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933are less likely to seek physician care or have CAD
risk factors identified on an incidental basis. More-
over because health issues are a more future-oriented
concern in younger than in older individuals, they
are more prone to postpone acting on health advice
(14). Such procrastination, although common, is
unfortunate because behavioral and medical inter-
vention in younger adults offers the greatest oppor-
tunity to ward off risk factors that will result from
negative health habits, such as poor nutrition,
overeating, sedentary lifestyles, and smoking. The
presence of a favorable risk factor profile in young
adults is highly predictive of longer longevity (15)
and improved quality of life and lower medical costs
in old age (16,17). In fact, seminal work from the
Framingham study revealed that if one makes it to
age 50 with a completely normal CAD risk profile,
the subsequent lifetime risk of the development of
clinical CAD is reduced by90% in women and by
80% in men (18).
Potentially, the application of CAC scanning in
early middle age may be beneficial by heightening
physician concern and thus their subsequent med-
ical management of patients with CAC abnormal-
ities and/or by motivating subjects toward greater
health self-care. Recent experience from the EIS-
NER (Early Identification of Subclinical Athero-
sclerosis by Noninvasive Imaging Research) trial,
which compared the 4-year impact randomized to10-year Framingham Risk Score: the men. Am J Cardiolmiddle-age adults, might be instructive in this
regard (19). The study demonstrated that CAC
scanning results in less FRS progression without
any increase in downstream medical resource use.
However, caution must be applied in applying the
results of the EISNER trial to young adults. In
particular, it remains to be determined whether
CAC scanning could indeed improve behavior by
motivating young subjects with evidence of CAC
abnormality to become more present oriented as to
their health risk and thereby more serious with
respect to initiating behavioral change.
In conclusion, the present study by Okwuosa et
al. (4) provides important information regarding the
selective use of CAC scanning to screen for CAD
among asymptomatic individuals between 33 and
45 years of age. Further study should assess whether
a risk score that accounts for the impact of risk
factors over time is better than the FRS for selecting
patients for CAC scanning. In the interim, given
the increased risk associated with any CAC abnor-
mality, we suggest that a FRS score 5% would be
a more effective threshold for applying CAC scan-
ning in young middle aged adults.
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